UAE: Sotrovimab Drug is 100% Effective in Preventing Death
- Publish date: Thursday، 22 December 2022
- Related articles
- Customs in Oman Foil Drug Smuggling Attempts
- CDAA Teams Successfully Extinguish Boat Fire at Khasab Port
- Oman is Introducing Tax Incentives to Encourage Drivers to Buy EVs
According to the latest study results released by UAE's MoHAP, Sotrovimab is 100% effective in preventing death.
The anti-viral medicine for COVID-19 showed that 97% of the recipients recovered within 14 days and prevented ICU admission in 99% of the cases.
مجموعة من الأطباء في شركة أبوظبي للخدمات الصحية "صحة" يتحدثون عن فعالية عقار سوتروفيماب لعلاج الحالات الخطرة المصابة بـ #كوفيد_19. pic.twitter.com/HRy0enHaiz
— مكتب أبوظبي الإعلامي (@admediaoffice) July 17, 2021
The study was carried out between June 30 and July 13 in collaboration with the Abu Dhabi Department of Health and Dubai Health Authority (DHA).
Over 6,100 patients were given the anti-viral medicine, of which 52% were aged 50 or above and had multiple pre-existing medical conditions.
Read More: UAE First Country To Approve New Treatment
The UAE was one of the first countries to receive the shipment of the medicine and had approved its use in June.
This article was previously published on UAE Moments.To see the original article, click here